好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C173 - Comprehensive Migraine 好色先生 Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances

Wednesday 04/26/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Gretchen E. Tietjen, MD
Participants should be able to apply criteria for the clinical diagnosis and differential diagnosis of chronic migraine and episodic migraine using diagnostic algorithms; recognize the scope, burden, and distribution of chronic migraine in the population as well as the risk factors that predispose to it; and describe emerging insights into the pathophysiology of chronic migraine.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Case-based, Didactic
Event Timeline
03:30 PM - 03:45 PM Luncheon Introduction
Gretchen E. Tietjen, MD
03:45 PM - 04:15 PM Speaker Behavioral and Psychological Aspects of Migraine
Dawn C. Buse, PhD
04:15 PM - 04:45 PM Speaker Preventive Medications for Chronic Migraine
Elizabeth Loder, MD, MPH
04:45 PM - 05:15 PM Speaker Advances in Acute Treatment of Migraine
Gretchen E. Tietjen, MD
05:15 PM - 05:30 PM Q&A Questions and Answers
Faculty Disclosures
Gretchen E. Tietjen, MD Dr. Tietjen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Tietjen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CME Outfitters. An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Elizabeth Loder, MD, MPH Dr. Loder has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Loder has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The BMJ.